Growth Metrics

NeuroPace (NPCE) Net Cash Flow (QoQ) (2020 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 NeuroPace 558.86 Mn 504.88 Mn 18.05 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -692.24%
Dec 31, 2025 147.96%
Sep 30, 2025 47.87%
Jun 30, 2025 -130.77%
Mar 31, 2025 817.66%
Dec 31, 2024 -174.86%
Sep 30, 2024 1,740.26%
Jun 30, 2024 96.96%
Mar 31, 2024 -160.66%
Dec 31, 2023 338.08%
Sep 30, 2023 74.20%
Jun 30, 2023 850.43%
Mar 31, 2023 -86.63%
Dec 31, 2022 7,066.67%
Sep 30, 2022 100.67%
Jun 30, 2022 84.72%
Mar 31, 2022 -57.17%
Dec 31, 2021 -60.41%
Sep 30, 2021 -127.04%
Jun 30, 2021 236.76%
Mar 31, 2021 24.97%
Dec 31, 2020 -150.49%
Sep 30, 2020 4,679.94%
Jun 30, 2020 -87.51%